Company intelligence / Profile preview

Kimia Kala Razi

Tehran, Tehran, Iran

Ownership: Private
Development stage: Other

Overview

Kimia Kala Razi is a prominent Iranian pharmaceutical company focused on the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2003, the company provides a diverse portfolio of generic medications across several therapeutic areas, including cardiovascular, gastrointestinal, and central nervous system disorders. The firm operates advanced manufacturing facilities in Iran that comply with international Good Manufacturing Practice (GMP) standards. Kimia Kala Razi serves as a critical supplier within the regional healthcare market, emphasizing self-sufficiency in essential medicine production and high-quality chemical synthesis.

Therapeutic areas: NeurologyGastroenterologyCardiovascularImmunology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Kimia Kala Razi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kimia Kala Razi.

Explore the full profile